SEC Comment Letter 0000000000-23-001680 to Apollomics Inc. (APLM, APLMW) (CIK 0001944885) (APLM)
Apollomics Inc. (APLM, APLMW) (CIK 0001944885)
Date: Feb. 17, 2023 · CIK: 0001944885 · Accession: 0000000000-23-001680
AI Filing Summary & Sentiment
File numbers found in text: 333-268525
Letter
United States securities and exchange commission logo February 17, 2023 Guo-Liang Yu Chief Executive Officer Apollomics Inc. 989 E. Hillsdale Blvd., Suite 220 Foster City, CA 94404 Re:Apollomics Inc. Amendment No. 3 to Registration Statement on Form F-4 Filed February 10, 2023 File No. 333-268525 Dear Guo-Liang Yu: We have reviewed your amended registration statement and have the following comment. In our comment, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments. Amendment No. 3 to Registration Statement on Form F-4 Summary of the Proxy Statement/Prospectus Subscription Agreements, page 36 1.We note that certain accredited investors have entered into subscription agreements to purchase Apollomics Class B Ordinary Shares and Apollomics Series A Preferred Shares in connection with the business combination. Please further highlight the material differences in the terms and price of securities issued at the time of the IPO as compared to private placements contemplated at the time of the business combination. Please also disclose if any of Maxpro's sponsors, directors, officers or their affiliates will participate in this private placement.
FirstName LastNameGuo-Liang Yu Comapany NameApollomics Inc. February 17, 2023 Page 2 FirstName LastName Guo-Liang Yu Apollomics Inc. February 17, 2023 Page 2 You may contact Christine Torney at 202-551-3652 or Kevin Vaughn at 202-551-3494 if you have questions regarding comments on the financial statements and related matters. Please contact Tyler Howes at 202-551-3370 or Suzanne Hayes at 202-551-3675 with any other questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Daniel Nussen, Esq.
Show Raw Text
United States securities and exchange commission logo
February 17, 2023
Guo-Liang Yu
Chief Executive Officer
Apollomics Inc.
989 E. Hillsdale Blvd., Suite 220
Foster City, CA 94404
Re:Apollomics Inc.
Amendment No. 3 to Registration Statement on Form F-4
Filed February 10, 2023
File No. 333-268525
Dear Guo-Liang Yu:
We have reviewed your amended registration statement and have the following
comment. In our comment, we may ask you to provide us with information so we may better
understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments.
Amendment No. 3 to Registration Statement on Form F-4
Summary of the Proxy Statement/Prospectus
Subscription Agreements, page 36
1.We note that certain accredited investors have entered into subscription agreements to
purchase Apollomics Class B Ordinary Shares and Apollomics Series A Preferred Shares
in connection with the business combination. Please further highlight the material
differences in the terms and price of securities issued at the time of the IPO as compared
to private placements contemplated at the time of the business combination. Please also
disclose if any of Maxpro's sponsors, directors, officers or their affiliates will
participate in this private placement.
FirstName LastNameGuo-Liang Yu
Comapany NameApollomics Inc.
February 17, 2023 Page 2
FirstName LastName
Guo-Liang Yu
Apollomics Inc.
February 17, 2023
Page 2
You may contact Christine Torney at 202-551-3652 or Kevin Vaughn at 202-551-3494 if
you have questions regarding comments on the financial statements and related matters. Please
contact Tyler Howes at 202-551-3370 or Suzanne Hayes at 202-551-3675 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Daniel Nussen, Esq.